Pharma & Biotech
XORTX Therapeutics Initiates Reverse Stock Split to Maintain Nasdaq Listing
In a strategic move to preserve its position on the Nasdaq exchange, XORTX Therapeutics is implementing a reverse stock split....
BioNTech’s Clinical Pipeline Offers Counterweight to Recent Stock Decline
Following a period of significant pressure after its founders announced their departure, BioNTech is shifting investor focus back to its...
Analyst Confidence Surges for Ocugen Following Clinical Trial Data
Positive results from a mid-stage clinical study have prompted several Wall Street research firms to revise their outlook on Ocugen,...
Eli Lilly’s Stock Hinges on Upcoming FDA Decision for Oral Weight-Loss Drug
Pharmaceutical giant Eli Lilly is approaching a pivotal regulatory milestone. The U.S. Food and Drug Administration (FDA) is expected to...
Hims & Hers Forges Strategic Alliance with Novo Nordisk, Pivots to Branded Weight-Loss Drugs
In a significant strategic shift, telehealth provider Hims & Hers has officially partnered with pharmaceutical giant Novo Nordisk, marking a...
BioNTech’s Oncology Pipeline Takes Center Stage at European Conference
The European Lung Cancer Congress in Copenhagen, which opens today, serves as a critical platform for BioNTech to showcase its...
Biotech Firm Ocugen Sees Major Price Target Revisions Following Clinical Data
A recent clinical trial update from Ocugen has prompted a significant reassessment of the company's prospects among Wall Street analysts....
Eli Lilly Faces Intensifying Competition in Weight-Loss Drug Arena
The pharmaceutical landscape for weight-loss medications is transforming into a fiercely competitive battleground. Recent clinical advancements from Danish rival Novo...
BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant corporate milestone announced...
Ocugen Shares Slide Despite Positive Clinical Trial Results
In a counterintuitive market reaction, Ocugen's stock price declined significantly following the announcement of encouraging 12-month data from its Phase...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
